SCHEMBL1012660

SCHEMBL1012660

C=CCOC(C)OP(=O)(O)O

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 3/20 0.32
LPAR2 Q9HBW0 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10781999 0.83 TDP1 (0.30) TDP1
SCHEMBL18048851 0.79 SMPD1 (0.30) SMPD1LPAR2LPAR3
SCHEMBL27990379 0.79 BTN3A1 (0.37) SMPD1LPAR2LPAR3
SCHEMBL1012535 0.77 SMPD1 (0.42) SMPD1LPAR2LPAR3
SCHEMBL2519350 0.76 SMPD1 (0.30) SMPD1LPAR2LPAR3
Phosphoric Acid SCHEMBL1012661 0.75 TDP1 (0.33) LPAR2LPAR3TDP1
SCHEMBL11298193 0.75 LAP3 (0.33) LPAR2LPAR3TDP1
SCHEMBL159503 0.75 LMNA (0.40) TDP1
SCHEMBL2045705 0.74 LMNA (0.50) SMPD1LPAR2LPAR3TDP1
Phosphoric Acid SCHEMBL10873638 0.73 LAP3 (0.37) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11337309-B2 Methods of manufacturing printed wire boards ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2022-05-17 US disclosed
CN-111683472-A Printed wiring board, method of manufacturing the same, and article including the same 罗门哈斯电子材料有限责任公司 2020-09-18 CN disclosed
US-20200296837-A1 PRINTED WIRE BOARDS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME ROHM & HAAS ELECT MAT (US) 2020-09-17 US disclosed
CN-109749000-A Low temperature curable addition polymers from vinyl aryl cyclobutene-containing monomers and methods for making the same 罗门哈斯电子材料有限责任公司 2019-05-14 CN disclosed
EP-3480223-A1 LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME Rohm and Haas Electronic Materials LLC (US) 2019-05-08 EP disclosed
US-20190127506-A1 LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME ROHM & HAAS ELECT MAT (US) 2019-05-02 US disclosed
EP-2842559-A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders Chimerix, Inc. (US) 2015-03-04 EP disclosed
US-20110015149-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS CHIMERIX, INC. 2011-01-20 US disclosed
EP-1865967-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS Chimerix, Inc. (US) 2007-12-19 EP disclosed
WO-2006110656-A9 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS CHIMERIX INC (US) 2007-03-01 WO disclosed
US-20070003608-A1 Compounds, compositions and methods for the treatment of viral infections and other medical disorders CHIMERIX, INC. 2007-01-04 US disclosed
WO-2006110656-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS CHIMERIX, INC. (US) 2006-10-19 WO disclosed
EP-0494169-B1 Process for the preparation of charged thermosetting polyurethane compositions and homogeneous and stable suspensions of the charge JAYMO S N C (FR) 1996-11-13 EP disclosed
EP-0494169-A1 PROCESS FOR THE PREPARATION OF CHARGED THERMOSETTING COMPOUNDS OF THE POLYURETHANE TYPE AND COMPOUNDS OBTAINED THEREBY. EXXON CHEMICAL PATENTS INC (US) 1992-07-15 EP disclosed
WO-1991003513-A1 PROCESS FOR THE PREPARATION OF CHARGED THERMOSETTING COMPOUNDS OF THE POLYURETHANE TYPE AND COMPOUNDS OBTAINED THEREBY EXXON CHEMICAL PATENTS INC. (US) 1991-03-21 WO disclosed
US-4703338-A Resin composition to seal electronic device DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1987-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127506-A1 LOW TEMPERATURE CURABLE ADDITION POLYMERS FROM VINYL ARYLCYCLOBUTENE-CONTAINING MONOMERS AND METHODS FOR MAKING THE SAME NOD2, CARM1, ACMSD SMPD1 4874/4885LPAR2 4759/4885LPAR3 4760/4885
US-20110015149-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER MEDICAL DISORDERS ACE, CYP27A1, LIPC SMPD1 57/4885LPAR2 1683/4885LPAR3 1414/4885
US-20070003608-A1 Compounds, compositions and methods for the treatment of viral infections and other medical disorders ACE, CYP27A1, LIPC SMPD1 57/4885LPAR2 1683/4885LPAR3 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.